Identical gene regulation patterns of T 3and selective thyroid hormone receptor modulator GC-1

Endocrinology

Volumn 153, Issue 1, 2012, Pages 501-511

  Yuan, Chaoshen ^b,c   Lin, Jean Z H ^a   Sieglaff, Douglas H ^a   Ayers, Steven D ^a   DeNoto Reynolds, Frances ^b   Baxter, John D ^a,b   Webb, Paul ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE FACTOR 4; HORMONE RECEPTOR STIMULATING AGENT; LIOTHYRONINE; SELECTIVE THYROID HORMONE RECEPTOR MODULATOR GC 1; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; EUTHYROIDISM; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENETIC VARIABILITY; HEPATOMA CELL; HUMAN; HUMAN CELL; HYPOTHYROIDISM; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ACETIC ACIDS; ANGIOPOIETINS; ANIMALS; BINDING SITES; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; LIVER; MALE; MICE; MICE, INBRED C57BL; PHENOLS; RECEPTORS, THYROID HORMONE; RNA, SMALL INTERFERING; THYROID HORMONE RECEPTORS ALPHA; THYROID HORMONE RECEPTORS BETA; TRIIODOTHYRONINE;

EID: 84455188475     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1325     Document Type: Article

References (35)

1. Baxter JD, Webb P 2009 Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat Rev Drug Discov 8:308-320
2. Yen PM 2001 Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097-1142 (Pubitemid 32606667)
3. Baxter JD, Webb P, Grover G, Scanlan TS 2004 Selective activation of thyroid hormone signaling pathways by GC-1: a new approach to controlling cholesterol and body weight. Trends Endocrinol Metab 15:154-157 (Pubitemid 38510494)
4. Forrest D, Vennström B 2000 Functions of thyroid hormone receptors in mice. Thyroid 10:41-52 (Pubitemid 30090364)
5. Trost SU, Swanson E, Gloss B, Wang-Iverson DB, Zhang H, Volodarsky T, Grover GJ, Baxter JD, Chiellini G, Scanlan TS, Dillmann WH 2000 The thyroid hormone receptor-β-selective agonist GC-1 differentially affects plasma lipids and cardiac activity. Endocrinology 141:3057-3064 (Pubitemid 32268991)
6. Grover GJ, Egan DM, Sleph PG, Beehler BC, Chiellini G, Nguyen NH, Baxter JD, Scanlan TS 2004 Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3′-triiodo-L-thyronine. Endocrinology 145:1656-1661 (Pubitemid 38402372)
7. Grover GJ, Mellström K, Ye L, Malm J, Li YL, Bladh LG, Sleph PG, Smith MA, George R, Vennström B, Mookhtiar K, Horvath R, Speelman J, Egan D, Baxter JD 2003 Selective thyroid hormone receptor-β activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability. Proc Natl Acad Sci USA 100:10067-10072 (Pubitemid 37098262)
8. Bryzgalova G, Effendic S, Khan A, Rehnmark S, Barbounis P, Boulet J, Dong G, Singh R, Shapses S, Malm J, Webb P, Baxter JD, Grover GJ 2008 Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor β subtype selective agonist KB-141. J Steroid Biochem Mol Biol 111:262-267
9. Perra A, Simbula G, Simbula M, Pibiri M, Kowalik MA, Sulas P, Cocco MT, Ledda-Columbano GM, Columbano A 2008 Thyroid hormone (T3) and TRβ agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats. FASEB J 22:2981-2989
10. Cable EE, Finn PD, Stebbins JW, Hou J, Ito BR, van Poelje PD, Linemeyer DL, Erion MD 2009 Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. Hepatology 49:407-417
11. Erion MD, Cable EE, Ito BR, Jiang H, Fujitaki JM, Finn PD, Zhang BH, Hou J, Boyer SH, van Poelje PD, Linemeyer DL 2007 Targeting thyroid hormone receptor-β agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index. Proc Natl Acad Sci USA 104:15490-15495 (Pubitemid 47502944)
12. Berkenstam A, Kristensen J, Mellström K, Carlsson B, Malm J, Rehnmark S, Garg N, Andersson CM, Rudling M, Sjöberg F, Angelin B, Baxter JD 2008 The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans. Proc Natl Acad Sci USA 105:663-667 (Pubitemid 351171765)
13. Ladenson PW, Kristensen JD, Ridgway EC, Olsson AG, Carlsson B, Klein I, Baxter JD, Angelin B 2010 Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia.New Engl J Med 362:906-916
14. Glass CK, Rosenfeld MG 2000 coregulator exchange in transcriptional functions of nuclear receptors. Gene Dev 14:121-141 (Pubitemid 30070977)
15. Togashi M, Borngraeber S, Sandler B, Fletterick RJ, Webb P, Baxter JD 2005 Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design. J Steroid Biochem Mol Biol 93:127-137 (Pubitemid 40602485)
16. Katzenellenbogen BS, Montano MM, Ediger TR, Sun J, Ekena K, Lazennec G, Martini PG, McInerney EM, Delage-Mourroux R, Weis K, Katzenellenbogen JA 2000 Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res 55:163-193; discussion 194-165
17. Nilsson M, Dahlman-Wright K, Gustafsson JA 2004 Nuclear receptors in disease: the oestrogen receptors. Essays Biochem 40:157-167 (Pubitemid 38906674)
18. Sears DD, Hsiao A, Ofrecio JM, Chapman J, He W, Olefsky JM 2007 Selective modulation of promoter recruitment and transcriptional activity of PPARγ. Biochem Biophys Res Commun 364:515-521 (Pubitemid 350026497)
19. Wang JC, Shah N, Pantoja C, Meijsing SH, Ho JD, Scanlan TS, Yamamoto KR 2006 Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity. Gene Dev 20: 689-699
20. Yen PM, Feng X, Flamant F, Chen Y, Walker RL, Weiss RE, Chassande O, Samarut J, Refetoff S, Meltzer PS 2003 Effects of ligand and thyroid hormone receptor isoforms on hepatic gene expression profiles of thyroid hormone receptor knockout mice. EMBO Rep 4:581-587 (Pubitemid 36939949)
21. Chan IH, Privalsky ML 2009 TR isoform-specific gene regulation. Mol Endocrinol 23:1758-1775
22. Wagner RL, Huber BR, Shiau AK, Kelly A, Cunha Lima ST, Scanlan TS, Apriletti JW, Baxter JD, West BL, Fletterick RJ 2001 Hormone selectivity in thyroid hormone receptors. Mol Endocrinol 15:398-410 (Pubitemid 32221917)
23. Gloss B, Giannocco G, Swanson EA, Moriscot AS, Chiellini G, Scanlan T, Baxter JD, Dillmann WH 2005 Different configurations of specific thyroid hormone response elements mediate opposite effects of thyroid hormone and GC-1 on gene expression. Endocrinology 146:4926-4933 (Pubitemid 41446631)
24. Moore JM, Galicia SJ, McReynolds AC, Nguyen NH, Scanlan TS, Guy RK 2004 Quantitative proteomics of the thyroid hormone receptor- coregulator interactions. J Biol Chem 279:27584-27590 (Pubitemid 38812599)
25. Amorim BS, Ueta CB, Freitas BC, Nassif RJ, Gouveia CH, Christoffolete MA, Moriscot AS, Lancelloti CL, Llimona F, Barbeiro HV, de Souza HP, Catanozi S, Passarelli M, Aoki MS, Bianco AC, Ribeiro MO 2009 A TRβ-selective agonist confers resistance to diet-induced obesity. J Endocrinol 203:291-299
26. Castillo M, Freitas BC, Rosene ML, Drigo RA, Grozovsky R, Maciel RM, Patti ME, Ribeiro MO, Bianco AC 2010 Impaired metabolic effects of a thyroid hormone receptor β-selective agonist in a mouse model of diet-induced obesity. Thyroid 20:545-553
27. Grijota-Martínez C, Samarut E, Scanlan TS, Morte B, Bernal J 2011 In vivo activity of the thyroid hormone receptor β- and α-selective agonists GC-24 and CO23 on rat liver, heart, and brain. Endocrinology 152:1136-1142
28. Samuels HH, Stanley F, Casanova J 1979 Depletion of L-3,5,3′- triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 105:80-85 (Pubitemid 9199127)
29. Johansson L, Rudling M, Scanlan TS, Lundåsen T, Webb P, Baxter J, Angelin B, Parini P 2005 Selective thyroid receptor modulation by GC-1reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice. Proc Natl Acad Sci USA 102:10297-10302 (Pubitemid 41024974)
30. Martínez L, Nascimento AS, Nunes FM, Phillips K, Aparicio R, Dias SM, Figueira AC, Lin JH, Nguyen P, Apriletti JW, Neves FA, Baxter JD, Webb P, Skaf MS, Polikarpov I 2009 Gaining ligand selectivity in thyroid hormone receptors via entropy. Proc Natl Acad Sci USA 106:20717-20722
31. Norris JD, Joseph JD, Sherk AB, Juzumiene D, Turnbull PS, Rafferty SW, Cui H, Anderson E, Fan D, Dye DA, Deng X, Kazmin D, Chang CY, Willson TM, McDonnell DP 2009 Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands. Chem Biol 16:452-460
32. Shih CH, Chen SL, Yen CC, Huang YH, Chen CD, Lee YS, Lin KH 2004 Thyroid hormone receptor-dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 145: 2804-2814 (Pubitemid 38686230)
33. Drover VA, Agellon LB 2004 Regulation of the human cholesterol 7α-hydroxylase gene (CYP7A1) by thyroid hormone in transgenic mice. Endocrinology 145:574-581 (Pubitemid 38183799)
34. Zandieh Doulabi B, Platvoet-ter Schiphorst M, van Beeren HC, Labruyere WT, Lamers WH, Fliers E, Bakker O, Wiersinga WM 2002 TR(β)1 protein is preferentially expressed in the pericentral zone of rat liver and exhibits marked diurnal variation. Endocrinology 143:979-984 (Pubitemid 34164046)
35. Yang X, Downes M, Yu RT, Bookout AL, He W, Straume M, Mangelsdorf DJ, Evans RM 2006 Nuclear receptor expression links the circadian clock to metabolism. Cell 126:801-810 (Pubitemid 44233631)